Fact CheckerSign in

NCT07032155Not yet recruiting

Virtual Reality in Occupational Therapy Upper Limb Stroke Rehabilitation

The Feasibility of Implementing Virtual Reality-based Upper Limb Rehabilitation for Stroke Patients and Occupational Therapists in an Acute Stroke Unit and Community Stroke Team, in Terms of Technology Acceptance, Safety and Usability

Source: ClinicalTrials.gov · Last updated 22 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study aims to assess the feasibility of using Resynk, a virtual reality (VR) software platform for upper limb rehabilitation for stroke survivors, both in acute hospital settings and in the community (home, private nursing home, residential home). Resynk offers interactive, task-oriented training that enhances therapy intensity and patient motivation. Previous findings from a Quality Improvement project showed significant increases in treatment intensity and patient engagement with Resynk. This study will explore barriers to Resynk implementation and gather input from staff participants and stroke survivors to ensure successful integration and effectiveness. Resynk will be delivered alongside standard care, with no intention to delay or reduce existing rehabilitation services. The study involves two participant groups -adult stroke survivors and Occupational Therapists. These represent realistic and appropriate user groups for this stage of implementation research. A control group is not included, as the primary aim is not comparative effectiveness but to assess feasibility and user experience. This study will use a exploratory approach to using qualitative methods for gather insight into safety, acceptability and usability such as the System usability Scale, EQ-5D-5L and custom design Questionnaire. Quantitative methods will be used for evaluating rehabilitating and function outcomes this includes data collected by the Resynk application and the standardised Fugl Meyers assessment. The study will involve pre, post and follow up data collection for both participant groups.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
5 Jun 2025
Start date
1 Jul 2025
Primary completion date
31 Dec 2025
Lead sponsor
eXRt Intelligent Healthcare
Diseases
Stroke
NCT number
NCT07032155

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Jul 2025 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Stroke onset more than 3 months prior to study entry.
  • Current participation in another clinical trial involving rehabilitation (e.g., recreational therapy, occupational therapy, physiotherapy) or an investigational drug that might interfere with study results.
  • Patients with implanted devices such as pacemakers, defibrillators, and cochlear implants.
  • Current participation in another clinical trial involving rehabilitation (e.g., recreational therapy, occupational therapy, physiotherapy) or an investigational drug that might interfere with study results.
  • Staff members with implanted devices such as pacemakers, defibrillators, and cochlear implants.

Other illness

  • Stroke Participants:
  • Patient is unable to follow verbal commands or has global aphasia. Interpreters may be used to accommodate stroke survivors' communication needs.
  • Severe illness with a life expectancy of less than 3 months (e.g., cancer, endocarditis, metastasis with an occult primary malignancy).
  • Uncontrolled hypertension as assessed by the treating physician.
  • Unstable angina or recent myocardial infarction.
  • Any history of epilepsy or seizures, except for febrile seizures of childhood.
  • Any physical health condition, mental health condition, or other medical condition or diagnosis that might confound the interpretation of results or put the patient at risk (e.g., amputation of one extremity).
  • History of vertigo.
  • Uncontrolled hypertension as assessed by the treating physician.
  • Unstable angina or recent myocardial infarction
  • Any history of epilepsy, seizures, except for febrile seizures of childhood.
  • Any physical health condition, mental health condition, or other medical condition or diagnosis that might confound the interpretation of results or put the patient at risk (e.g., amputation of one extremity).
  • History of vertigo.

Other

  • Acutely medically unwell as per medical team
  • Patient is unwilling or unable to comply with the protocol or cannot/will not cooperate fully with the investigator or study personnel.
  • Active delirium/significant levels of confusion
  • Cervical artery dissection.
  • Individual currently being managed under the Mental Capacity Act
  • Staff participants:
  • Cervical artery dissection.

Who the study is looking for

  • Stroke Participants
  • Able to provide informed consent
  • Aged over 18 years.
  • Evidence of stroke confirmed by medical team
  • Newly diagnosed patients who are admitted to the acute stroke unit with a confirmed diagnosis of stroke.
  • More than 48 hours since stroke event
  • Patient is appropriate to participate in rehabilitation according to the treating physician or medical consultant, and able to follow simple verbal commands.
  • Presence of an upper limb deficit identified in the NIHSS (National Institutes of Health Stroke Scale) or by a member of the medical or multidisciplinary team
  • Residents within the Belfast health and social care trust catchment area/postcode
  • Staff participants:
  • Qualified Registered Occupational Therapy Staff who work in the Stroke Unit in the Royal Victoria Hospital Belfast or in the Community Stroke Team in the Belfast Health and Social Care Trust.
  • Able to provide informed consent
  • Aged 18 or over

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Victoria Hospital
Coordinator of this site? Confirm its status
BelfastUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.